Entero Therapeutics
Why Robinhood?
You can watch ENTO and buy or sell other stocks, ETFs, and their options commission-free!About ENTO
GridAI Technologies Corp. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide.
ENTO Key Statistics
Stock Snapshot
The current Entero Therapeutics(ENTO) stock price is $4.78, with a market capitalization of 12.18M. The stock trades at a price-to-earnings (P/E) ratio of -0.23.
On 2026-03-12, Entero Therapeutics(ENTO) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 141.12K.
The stock's 52-week range extends from a low of $0.97 to a high of $5.84.
The stock's 52-week range extends from a low of $0.97 to a high of $5.84.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.